Clinical Trials Directory

Trials / Unknown

UnknownNCT04856670

Assessing Diabetes Mellitus on Cytokine Analysis and Macular Edema Following FLACS

Assessing the Impact of Diabetes Mellitus on Anterior Chamber Cytokine Production and Postoperative Macular Edema in Patients Undergoing Femtosecond Laser-assisted Cataract Surgery

Status
Unknown
Phase
Study type
Observational
Enrollment
140 (estimated)
Sponsor
Uptown Eye Specialists · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the effects of diabetes mellitus (DM) on anterior chamber cytokine production and postoperative macular edema in patients undergoing femtosecond laser-assisted cataract surgery (FLACS). Patients with DM routinely undergo FLACS, yet the majority of studies evaluating intraocular inflammation following femtosecond laser treatment have excluded this patient population. Importantly, DM alters the inflammatory status of the eye, which may influence the production of inflammatory mediators following femtosecond laser treatment and the development of postoperative macular edema. The results from this study will provide insight into the risks and benefits of FLACS in patients with DM.

Detailed description

As discussed above.

Conditions

Interventions

TypeNameDescription
PROCEDURECataract surgeryCataract surgery- Manual or femtosecond laser assisted

Timeline

Start date
2021-05-25
Primary completion
2021-09-15
Completion
2021-09-15
First posted
2021-04-23
Last updated
2021-05-12

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04856670. Inclusion in this directory is not an endorsement.